Chapter/Section Purchase

1 Trastuzumab Emtansine for Injection Market Overview
1.1 Product Overview and Scope of Trastuzumab Emtansine for Injection
1.2 Trastuzumab Emtansine for Injection Segment by Type
1.2.1 Global Trastuzumab Emtansine for Injection Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 60mg
1.2.3 100mg
1.2.4 150mg
1.2.5 160mg
1.2.6 Others
1.3 Trastuzumab Emtansine for Injection Segment by Application
1.3.1 Global Trastuzumab Emtansine for Injection Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Trastuzumab Emtansine for Injection Market Size Estimates and Forecasts
1.4.1 Global Trastuzumab Emtansine for Injection Revenue 2017-2028
1.4.2 Global Trastuzumab Emtansine for Injection Sales 2017-2028
1.4.3 Trastuzumab Emtansine for Injection Market Size by Region: 2017 Versus 2021 Versus 2028
2 Trastuzumab Emtansine for Injection Market Competition by Manufacturers
2.1 Global Trastuzumab Emtansine for Injection Sales Market Share by Manufacturers (2017-2022)
2.2 Global Trastuzumab Emtansine for Injection Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Trastuzumab Emtansine for Injection Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Trastuzumab Emtansine for Injection Manufacturing Sites, Area Served, Product Type
2.5 Trastuzumab Emtansine for Injection Market Competitive Situation and Trends
2.5.1 Trastuzumab Emtansine for Injection Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Trastuzumab Emtansine for Injection Players Market Share by Revenue
2.5.3 Global Trastuzumab Emtansine for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Trastuzumab Emtansine for Injection Retrospective Market Scenario by Region
3.1 Global Trastuzumab Emtansine for Injection Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Trastuzumab Emtansine for Injection Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Trastuzumab Emtansine for Injection Market Facts & Figures by Country
3.3.1 North America Trastuzumab Emtansine for Injection Sales by Country
3.3.2 North America Trastuzumab Emtansine for Injection Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Trastuzumab Emtansine for Injection Market Facts & Figures by Country
3.4.1 Europe Trastuzumab Emtansine for Injection Sales by Country
3.4.2 Europe Trastuzumab Emtansine for Injection Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Trastuzumab Emtansine for Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Trastuzumab Emtansine for Injection Sales by Region
3.5.2 Asia Pacific Trastuzumab Emtansine for Injection Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Trastuzumab Emtansine for Injection Market Facts & Figures by Country
3.6.1 Latin America Trastuzumab Emtansine for Injection Sales by Country
3.6.2 Latin America Trastuzumab Emtansine for Injection Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Trastuzumab Emtansine for Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Trastuzumab Emtansine for Injection Sales by Country
3.7.2 Middle East and Africa Trastuzumab Emtansine for Injection Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Trastuzumab Emtansine for Injection Historic Market Analysis by Type
4.1 Global Trastuzumab Emtansine for Injection Sales Market Share by Type (2017-2022)
4.2 Global Trastuzumab Emtansine for Injection Revenue Market Share by Type (2017-2022)
4.3 Global Trastuzumab Emtansine for Injection Price by Type (2017-2022)
5 Global Trastuzumab Emtansine for Injection Historic Market Analysis by Application
5.1 Global Trastuzumab Emtansine for Injection Sales Market Share by Application (2017-2022)
5.2 Global Trastuzumab Emtansine for Injection Revenue Market Share by Application (2017-2022)
5.3 Global Trastuzumab Emtansine for Injection Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Genentech
6.1.1 Genentech Corporation Information
6.1.2 Genentech Description and Business Overview
6.1.3 Genentech Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Genentech Trastuzumab Emtansine for Injection Product Portfolio
6.1.5 Genentech Recent Developments/Updates
6.2 Daiichi Sankyo
6.2.1 Daiichi Sankyo Corporation Information
6.2.2 Daiichi Sankyo Description and Business Overview
6.2.3 Daiichi Sankyo Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Daiichi Sankyo Trastuzumab Emtansine for Injection Product Portfolio
6.2.5 Daiichi Sankyo Recent Developments/Updates
6.3 Amgen
6.3.1 Amgen Corporation Information
6.3.2 Amgen Description and Business Overview
6.3.3 Amgen Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Amgen Trastuzumab Emtansine for Injection Product Portfolio
6.3.5 Amgen Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Pfizer Trastuzumab Emtansine for Injection Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Samsung Bioepis
6.5.1 Samsung Bioepis Corporation Information
6.5.2 Samsung Bioepis Description and Business Overview
6.5.3 Samsung Bioepis Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Samsung Bioepis Trastuzumab Emtansine for Injection Product Portfolio
6.5.5 Samsung Bioepis Recent Developments/Updates
6.6 Mylan(Viatris)
6.6.1 Mylan(Viatris) Corporation Information
6.6.2 Mylan(Viatris) Description and Business Overview
6.6.3 Mylan(Viatris) Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Mylan(Viatris) Trastuzumab Emtansine for Injection Product Portfolio
6.6.5 Mylan(Viatris) Recent Developments/Updates
6.7 Celltrion
6.6.1 Celltrion Corporation Information
6.6.2 Celltrion Description and Business Overview
6.6.3 Celltrion Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Celltrion Trastuzumab Emtansine for Injection Product Portfolio
6.7.5 Celltrion Recent Developments/Updates
6.8 Roche
6.8.1 Roche Corporation Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Roche Trastuzumab Emtansine for Injection Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 Accord Healthcare
6.9.1 Accord Healthcare Corporation Information
6.9.2 Accord Healthcare Description and Business Overview
6.9.3 Accord Healthcare Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Accord Healthcare Trastuzumab Emtansine for Injection Product Portfolio
6.9.5 Accord Healthcare Recent Developments/Updates
6.10 Nippon Kayaku
6.10.1 Nippon Kayaku Corporation Information
6.10.2 Nippon Kayaku Description and Business Overview
6.10.3 Nippon Kayaku Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Nippon Kayaku Trastuzumab Emtansine for Injection Product Portfolio
6.10.5 Nippon Kayaku Recent Developments/Updates
6.11 Chugai Pharmaceutical
6.11.1 Chugai Pharmaceutical Corporation Information
6.11.2 Chugai Pharmaceutical Trastuzumab Emtansine for Injection Description and Business Overview
6.11.3 Chugai Pharmaceutical Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Chugai Pharmaceutical Trastuzumab Emtansine for Injection Product Portfolio
6.11.5 Chugai Pharmaceutical Recent Developments/Updates
6.12 Henlius
6.12.1 Henlius Corporation Information
6.12.2 Henlius Trastuzumab Emtansine for Injection Description and Business Overview
6.12.3 Henlius Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Henlius Trastuzumab Emtansine for Injection Product Portfolio
6.12.5 Henlius Recent Developments/Updates
6.13 Orifarm
6.13.1 Orifarm Corporation Information
6.13.2 Orifarm Trastuzumab Emtansine for Injection Description and Business Overview
6.13.3 Orifarm Trastuzumab Emtansine for Injection Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Orifarm Trastuzumab Emtansine for Injection Product Portfolio
6.13.5 Orifarm Recent Developments/Updates
7 Trastuzumab Emtansine for Injection Manufacturing Cost Analysis
7.1 Trastuzumab Emtansine for Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Trastuzumab Emtansine for Injection
7.4 Trastuzumab Emtansine for Injection Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Trastuzumab Emtansine for Injection Distributors List
8.3 Trastuzumab Emtansine for Injection Customers
9 Trastuzumab Emtansine for Injection Market Dynamics
9.1 Trastuzumab Emtansine for Injection Industry Trends
9.2 Trastuzumab Emtansine for Injection Market Drivers
9.3 Trastuzumab Emtansine for Injection Market Challenges
9.4 Trastuzumab Emtansine for Injection Market Restraints
10 Global Market Forecast
10.1 Trastuzumab Emtansine for Injection Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Trastuzumab Emtansine for Injection by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Trastuzumab Emtansine for Injection by Type (2023-2028)
10.2 Trastuzumab Emtansine for Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Trastuzumab Emtansine for Injection by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Trastuzumab Emtansine for Injection by Application (2023-2028)
10.3 Trastuzumab Emtansine for Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Trastuzumab Emtansine for Injection by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Trastuzumab Emtansine for Injection by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer